Especificación
- 100mg de polvo
| Información del producto | |
|---|---|
| CAS | 1119-34-2 |
| Nombre chino | L-精氨酸盐酸盐 |
| Nombre en inglés | L-Arginine Hydrochloride |
| Sinónimos |
|
| Fórmula molecular | C6H14N4O2·HCl |
| Peso molecular | 210.66 |
| Especificaciones | 10mM*1mL in Water; 100mg |
| Solubilidad | Soluble in Water ≥10mg/mL |
| Condiciones de almacenaje | Polvo: 2-8℃, 2 años; en solución: -20℃, 6 meses; -80℃, 1 año |
| Pureza | HPLC≥98% |
| Apariencia | Blanco a blanquecino Sólido |
| Unidad | Botella |
| CE | EINECS 214-275-1 |
| MDL | MFCD00064550 |
| SONRISAS | NC@@HC(oh)=O.[h]Cl |
| InChiKey | KWTQSFXGGICVPE-WCCKRBBISA-N |
| InChi | InChI=1S/C6H14N4O2.ClH/c7-4(5(11)12)2-1-3-10-6(8)9;/h4H,1-3,7H2,(h,11,12)(H4,8,9,10);1H/t4-;/m0./s1 |
| PubChem CID | 66250 |
| Objetivos | Otros |
| Camino | Otros |
| Información previa | Reported to be an effective vasodilator used to induce experimental acute pancreatitis. |
| Biological Activity | L-Arginine HCl (L-Arg) is a nitrogen donor for nitric oxide synthesis, acting as an effective vasodilator, often deficient in sickle cell anemia [1-2]. |
| In Vitro | Supplementation of L-Arginine (0.3 milímetro, 30 minutos) increases NO concentration twofold in bovine aortic endothelial cells with an LDL concentration of 60-130 mg cholesterol/dL. In conditions with low LDL, L-Arginine (0.3 milímetro, 30 minutos) does not increase NO peak concentration or O2- levels. Pre-treatment with L-Arginine reduces O2- production by 50% when incubated with n-LDL above 40mg cholesterol/dL and completely inhibits O2- production from oxidized LDL doses [1]. |
| In Vivo | In rabbit limbs with ischemia/reperfusion injury, L-Arginine (4 mg/kg/min for 1 hora) reduces superoxide production by cNOS, increases NO accumulation, prevents microvascular contraction, and significantly reduces muscle edema [2]. |
| Referencias | [1]. Vergnani L, et al. Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production: key role of L-arginine availability. Circulation. 2000 Mar 21;101(11):1261-6.
[2]. Huk I, et al. L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation. 1997 Jul 15;96(2):667-75. |
Reseñas
Aún no hay reseñas.